Results 231 to 240 of about 88,362 (256)
Clinical features and prognosis analysis of patients with follicular lymphoma: a real-world study in China. [PDF]
Ann HematolSu Y +8 more
europepmc +1 more source
Current immunotherapeutic approaches for relapsed/refractory follicular lymphoma: bispecific antibodies and CAR T-Cell therapies. [PDF]
Blood ResPark SY, Min GJ.
europepmc +1 more source
Follicular Lymphoma: Current Therapeutic Landscape and Future Prospects. [PDF]
Hematol OncolKumar E, Okosun J.
europepmc +1 more source
Systematic review and meta-analysis: CAR-T vs bispecific antibody as third or later-line therapy for follicular lymphoma. [PDF]
Blood Cancer JNg LCK +10 more
europepmc +1 more source
A Rare Case of Primary Follicular Lymphoma in the Retroperitoneum. [PDF]
CureusMathew T +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Critical Reviews in Oncology/Hematology, 2008
Follicular lymphomas constitute approximately 30% of all non-Hodgkin lymphomas. These lymphomas are characterized by at least partially follicular growth pattern, but diffuse areas may be present. The proportions of follicular or diffuse areas vary also from case to case, which seems to be associated with prognosis.
Umberto, Vitolo +2 more
openaire +2 more sources
Follicular lymphomas constitute approximately 30% of all non-Hodgkin lymphomas. These lymphomas are characterized by at least partially follicular growth pattern, but diffuse areas may be present. The proportions of follicular or diffuse areas vary also from case to case, which seems to be associated with prognosis.
Umberto, Vitolo +2 more
openaire +2 more sources
2021
Follicular lymphoma (FL) is an indolent yet challenging disease. Despite a generally favorable response to immunochemotherapy regimens, a fraction of patients does not respond or relapses early with unfavorable prognosis. For the vast majority of those who initially respond, relapses will repeatedly occur with increasing refractoriness to available ...
Milpied, Pierre +6 more
openaire +3 more sources
Follicular lymphoma (FL) is an indolent yet challenging disease. Despite a generally favorable response to immunochemotherapy regimens, a fraction of patients does not respond or relapses early with unfavorable prognosis. For the vast majority of those who initially respond, relapses will repeatedly occur with increasing refractoriness to available ...
Milpied, Pierre +6 more
openaire +3 more sources
Intramuscular Follicular Lymphoma
Clinical Nuclear Medicine, 2018Abstract We present an interesting image of a painless growing mass of the right arm in a 76-year-old man. A musculoskeletal MRI of the right arm showed a 7.5 × 3-cm homogeneous, well-defined mass, elongated along the course of muscle fascias and independent of the adjacent bone.
Filipe, Martins +4 more
openaire +2 more sources
The American Journal of Surgical Pathology, 1986
Fifteen cases of cutaneous follicular lymphoma were evaluated clinically, histologically, and immunologically. Nine of the patients presented with skin disease alone, which showed a predilection for the scalp and forehead. The six remaining cases had either concurrent or secondary cutaneous involvement.
C F, Garcia +3 more
openaire +2 more sources
Fifteen cases of cutaneous follicular lymphoma were evaluated clinically, histologically, and immunologically. Nine of the patients presented with skin disease alone, which showed a predilection for the scalp and forehead. The six remaining cases had either concurrent or secondary cutaneous involvement.
C F, Garcia +3 more
openaire +2 more sources